Biotech Names to Watch: Amgen and AVI
Amgen stays strong, AVI emerging from consolidation. Hear Bill and the committee’s take on these biotech names and what could happen next. Segment begins with Bill Baruch at 2:28 Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.